In this note we go over the most important drivers of our business case. We provide a breakdown of our organic growth assumptions and shift some of the recovery from FY25 to FY26. We reduce acquisitional growth due to lower spillover from 2024 acquisitions and provide a detailed overview of expected acquisition dynamics. Our long term Gross profit margin forecasts increase, due to structural improvements. We expect significant operational leverage given the elevated OpEx levels, due to acquisiti...
IMCD reports EBITA growth to EUR 531 million in 2024 Rotterdam, The Netherlands (5 March 2025) - IMCD N.V. (“IMCD” or “Company”), a global leading distribution partner, and formulator of speciality chemicals and ingredients, today announces its full year 2024 results. HIGHLIGHTS• Gross profit growth of 7% to EUR 1,202 million (+9% on a constant currency basis)• Operating EBITA increase of 3% to EUR 531 million (+5% on a constant currency basis)• Net result for the year of EUR 278 million (-4% on a constant currency basis)• Free cash flow of EUR 450 million (2023: EUR 554 million)• Cash ear...
IMCD takes the next steps in its decarbonisation journey and commits to set SBTi near-term targets ROTTERDAM, The Netherlands (3 March 2025) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner and formulator of speciality chemicals and ingredients, today announced it has committed to the Science Based Target initiative (SBTi) and intends to set near-term emissions reduction targets in line the SBTi criteria and recommendations. The SBTi is a corporate climate action organisation that enables companies and financial institutions worldwide to play their part in combating...
After 4% organic gross profit growth in 2Q24 we saw 7% in 3Q24 which is in line with long-term trends but also thanks to easy comps. With 5% for FY25F and 7% for FY26F, the outlook is strong and supportive to the coverage of costs which has recently put pressure on EBITA and conversion margins. IMCD is in excellent shape in our view - the company's track record in growth, value enhancement and M&A continues, and its strong asset light model is intact. At 15.4x EV/EBITDA 2024-26F we see upside fo...
Aalberts: highlights ING Benelux Conference Brussels 2024, Ackermans & Van Haaren: Highlights ING Benelux Conference Brussels,Ackermans & Van Haaren: Strong operational performance of underlying companies and guidance fine-tuned upwards, AMG: Highlights ING Benelux Conference Brussels, Aperam: Highlights ING Benelux Conference Brussels, Arcadis: Highlights ING Benelux conference, Azelis: Highlights ING Benelux Conference Brussels, Bekaert: Guidance cut and €200m buyback as sweetener, CFE: No new...
IMCD N.V. successfully raises EUR 300 million through an accelerated bookbuild offering of new shares NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT.ROTTERDAM, The Netherland...
IMCD N.V. LAUNCHES A CAPITAL RAISE OF EUR 300 MILLION TO INCREASE FINANCIAL FLEXIBILITY NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, INTO OR IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH OFFERS OR SALES WOULD BE PROHIBITED BY APPLICABLE LAW. THIS ANNOUNCEMENT DOES NOT CONSTITUTE OR FORM AN OFFER OF SECURITIES IN THE UNITED STATES, CANADA, AUSTRALIA, JAPAN, SOUTH AFRICA OR ANY OTHER JURISDICTION.PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. ROTTERDAM, The Netherlands (12 Novembe...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.